Government contractors, health-related groups and the medical marijuana industry were among hundreds of organizations that spent $9.1 million lobbying Kentucky's executive branch agencies on policy in ...

A GOP congressional leader says he’s “cautiously optimistic” that President Donald Trump will move forward with marijuana ...

Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs ...

Workers in the Dwight facility 80 miles south of Chicago will lose their jobs when the operation closes in January.

Eight publicly traded marijuana businesses with sizable footprints in Illinois lost a cumulative $164 million in the third quarter of the 2025 calendar year.

/Germany/EU Regulatory Notice: This communication is not intended for patients or the general public in Germany or the EU and does not constitute advertising for prescription-only medicinal products.

“In Q3, we refinanced our debt and strengthened our balance sheet while delivering solid results and maintaining leadership across key markets through disciplined execution. Our proven retail and ...

Teens who start using cannabis before age 15 are more likely to use the drug often later in their lives. They are also more likely to develop mental and physical health problems in young adulthood ...

Scientists Studied 'SuperAgers' For 25 Years And Found That They All Have This 1 Habit In Common Border Patrol commander Bovino ordered to face federal judge in Chicago ESPNers Call Out Pat McAfee ...

The cannabis sector is back in the spotlight as the administration considers rescheduling. There have been no new updates, but the sector rally remains elevated in anticipation. Cresco Labs is down 14 ...

LINCOLN, Neb. – Nebraska officials missed a deadline this week granting licenses to marijuana growers as part of a voter-approved measure that legalized medical marijuana, offering the latest example ...

WASHINGTON (AP) — An experimental medication made from marijuana successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common ...